kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.14%39.88B | 5.93%34.96B | -12.98%140.2B | -9.08%31.85B | -21.00%34.04B | -12.69%41.31B | -7.50%33B | 30.36%161.11B | 1.93%35.03B | 33.92%43.09B |
Cost of revenue | 15.93%35.44B | 5.21%31.17B | -13.58%124.64B | -11.69%27.49B | -22.16%30.57B | -12.98%36.95B | -5.53%29.63B | 31.06%144.23B | 4.07%31.13B | 36.08%39.28B |
Gross profit | 27.87%4.43B | 12.31%3.79B | -7.84%15.55B | 11.75%4.36B | -9.03%3.47B | -10.16%4.36B | -21.88%3.37B | 24.74%16.88B | -12.40%3.9B | 15.04%3.81B |
Operating expense | 13.52%2.72B | 5.73%2.53B | -2.23%9.8B | -0.87%2.52B | -6.81%2.4B | -2.31%2.5B | 1.36%2.39B | 7.60%10.03B | -2.16%2.54B | 11.49%2.57B |
Operating profit | 60.00%1.71B | 28.45%1.26B | -16.05%5.75B | 35.27%1.84B | -13.64%1.07B | -18.91%1.86B | -49.97%977M | 62.70%6.85B | -26.71%1.36B | 23.16%1.24B |
Net non-operating interest income (expenses) | 48.00%-130M | 58.85%-93M | -18.74%-849M | 50.61%-122M | 8.09%-250M | -75.52%-251M | -326.42%-226M | -652.63%-715M | -782.14%-247M | -1,033.33%-272M |
Non-operating interest income | 47.83%34M | 80.77%47M | 200.00%114M | 105.56%37M | 187.50%23M | 300.00%28M | 420.00%26M | 100.00%38M | 260.00%18M | 60.00%8M |
Non-operating interest expense | -39.93%164M | -44.44%140M | 27.89%963M | -40.00%159M | -2.50%273M | 86.00%279M | 334.48%252M | 560.53%753M | 703.03%265M | 865.52%280M |
Net investment income | -6.86%-218M | -36.71%-283M | -60.34%-1.04B | -188.58%-318M | -255.73%-204M | 21.72%-310M | 72.10%-207M | -13.68%-648M | 270.95%359M | 160.65%131M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 11M | 91.89%-12M | 85.39%-26M | 0 | -53.33%14M | 0 | -174.07%-148M | -229.63%-178M | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -175.00%-11M | -150.00%-10M | -1M | 0 | 0 | -4M | -4M | 0 | |
Less:Other special charges | ---- | ---- | 175.00%11M | --10M | ---- | ---- | ---- | --4M | ---- | ---- |
Other non-operating income (expenses) | -77.78%2M | -171.43%-5M | 77.78%48M | -50.00%5M | 325.00%9M | 92.86%27M | 0.00%7M | 68.75%27M | 10M | -114.29%-4M |
Income before tax | 118.56%1.37B | 60.33%885M | -27.46%3.89B | 5.39%1.37B | -42.92%625M | -25.47%1.34B | -52.62%552M | 52.80%5.36B | -17.10%1.3B | 38.26%1.1B |
Income tax | 116.67%351M | -2.96%361M | -24.60%1.14B | -15.75%385M | -38.17%162M | -45.09%218M | -5.10%372M | 53.10%1.51B | 2.70%457M | 48.02%262M |
Net income | 119.48%1.01B | 192.18%523M | -28.59%2.75B | 16.86%984M | -44.47%462M | -19.84%1.12B | -76.84%179M | 52.70%3.85B | -24.89%842M | 35.06%832M |
Net income continuous operations | 119.22%1.02B | 191.11%524M | -28.58%2.75B | 16.86%984M | -44.42%463M | -19.91%1.12B | -76.71%180M | 52.68%3.85B | -24.96%842M | 35.45%833M |
Noncontrolling interests | 300.00%4M | -100.00%-6M | -46.67%8M | -133.33%-1M | -100.00%-2M | 100.00%14M | -150.00%-3M | 475.00%15M | 200.00%3M | -125.00%-1M |
Net income attributable to the company | 117.93%1.01B | 191.21%530M | -28.50%2.74B | 17.66%986M | -44.48%463M | -20.44%1.11B | -76.24%182M | 51.82%3.83B | -25.44%838M | 36.50%834M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 117.93%1.01B | 191.21%530M | -28.50%2.74B | 17.66%986M | -44.48%463M | -20.44%1.11B | -76.24%182M | 51.82%3.83B | -25.44%838M | 36.50%834M |
Gross dividend payment | ||||||||||
Basic earnings per share | 117.40%82.57 | 189.67%43.45 | -28.55%224.66 | 17.54%80.81 | -44.46%37.98 | -20.55%90.87 | -76.16%15 | 83.75%314.43 | -15.43%68.75 | 54.64%68.38 |
Diluted earnings per share | 117.44%82.4971 | 189.67%43.45 | -28.55%224.66 | 17.55%80.7972 | -43.97%37.9403 | -19.71%90.87 | -76.16%15 | 83.75%314.43 | -15.45%68.7317 | 53.13%67.7155 |
Dividend per share | 0 | 0 | -22.22%105 | -33.33%70 | 0 | 16.67%35 | 0 | 68.75%135 | 50.00%105 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |